BELITE BIO, INC

BLTE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001889109

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Sep 9, 20267:39 PM ETSep 4 – Sep 8, 2026Lin Yu-HsinChief Executive OfficerSSaleAmerican depositary share−100.44K$189.999−$19.08M70.13K−58.9%SEC10b5-1
Sep 9, 20267:38 PM ETSep 4 – Sep 8, 2026Chuang Hao-YuanChief Financial OfficerSSaleAmerican depositary share−67.4K$189.9774−$12.8M26.04K−72.1%SEC10b5-1
Aug 14, 20266:10 AM ETAug 12, 2026Chuang Hao-YuanChief Financial OfficerSSaleAmerican depositary share−367$180.3463−$66.19K93.43K−0.4%SEC10b5-1
Aug 14, 20266:10 AM ETAug 12, 2026Lin Yu-HsinChief Executive OfficerSSaleAmerican depositary share−365$180.3482−$65.83K170.57K−0.2%SEC10b5-1
Jun 22, 2026Jun 18, 2026Scholl Hendrik PeterChief Medical OfficerSSaleAmerican depositary share−10K$145.24−$1.45M15K−40.0%SEC
Jun 17, 2026Jun 16, 2026Scholl Hendrik PeterChief Medical OfficerSSaleAmerican depositary share−10K$140.573−$1.41M25K−28.6%SEC
May 8, 2026May 7, 2026MATA NATHAN L.Chief Scientific OfficerSSaleAmerican depositary share−666$153.2109−$102.04K0−100.0%SEC10b5-1
May 7, 2026May 6, 2026MATA NATHAN L.Chief Scientific OfficerSSaleAmerican depositary share−1K$153.8378−$153.84K666−60.0%SEC10b5-1
May 6, 2026May 5, 2026MATA NATHAN L.Chief Scientific OfficerSSaleAmerican depositary share−1K$155.5017−$155.5K1.67K−37.5%SEC10b5-1
May 5, 2026May 4, 2026MATA NATHAN L.Chief Scientific OfficerSSaleAmerican depositary share−1K$155.6381−$155.64K2.67K−27.3%SEC10b5-1
May 4, 2026May 1, 2026MATA NATHAN L.Chief Scientific OfficerSSaleAmerican depositary share−1K$155.779−$155.78K3.67K−21.4%SEC10b5-1
May 1, 2026Apr 30, 2026MATA NATHAN L.Chief Scientific OfficerSSaleAmerican depositary share−1K$156.9745−$156.97K4.67K−17.6%SEC10b5-1
Apr 30, 2026Apr 29, 2026MATA NATHAN L.Chief Scientific OfficerSSaleAmerican depositary share−1K$155.8167−$155.82K5.67K−15.0%SEC10b5-1
Apr 29, 2026Apr 28, 2026MATA NATHAN L.Chief Scientific OfficerSSaleAmerican depositary share−1K$159.1625−$159.16K6.67K−13.0%SEC10b5-1
Apr 28, 2026Apr 27, 2026MATA NATHAN L.Chief Scientific OfficerSSaleAmerican depositary share−1K$162.6425−$162.64K7.67K−11.5%SEC10b5-1
Apr 27, 2026Apr 24, 2026MATA NATHAN L.Chief Scientific OfficerSSaleAmerican depositary share−1K$159.5564−$159.56K8.67K−10.3%SEC10b5-1
Apr 24, 2026Apr 23, 2026MATA NATHAN L.Chief Scientific OfficerSSaleAmerican depositary share−1K$166.2816−$166.28K9.67K−9.4%SEC10b5-1
Apr 23, 2026Apr 22, 2026MATA NATHAN L.Chief Scientific OfficerSSaleAmerican depositary share−1K$170.3853−$170.39K10.67K−8.6%SEC10b5-1
Apr 22, 2026Apr 21, 2026MATA NATHAN L.Chief Scientific OfficerSSaleAmerican depositary share−1K$166.0005−$166K11.67K−7.9%SEC10b5-1
Apr 21, 2026Apr 20, 2026MATA NATHAN L.Chief Scientific OfficerSSaleAmerican depositary share−1K$163.5961−$163.6K12.67K−7.3%SEC10b5-1
Apr 20, 2026Apr 17, 2026MATA NATHAN L.Chief Scientific OfficerSSaleAmerican depositary share−1K$161.6308−$161.63K13.67K−6.8%SEC10b5-1
Apr 20, 2026Apr 16, 2026MATA NATHAN L.Chief Scientific OfficerSSaleAmerican depositary share−1K$160.3804−$160.38K14.67K−6.4%SEC10b5-1
Apr 16, 2026Apr 15, 2026MATA NATHAN L.Chief Scientific OfficerSSaleAmerican depositary share−1K$168.2959−$168.3K15.67K−6.0%SEC10b5-1
Apr 13, 2026Apr 9, 2026Lin Yu-HsinChief Executive OfficerSSaleAmerican depositary share−9.2K$181.4516−$1.67M170.93K−5.1%SEC10b5-1
Apr 13, 2026Apr 9, 2026Chen Wan-ShanDirectorSSaleAmerican depositary share−1.1K$180.43−$198.47K9.1K−10.8%SEC10b5-1
Apr 13, 2026Apr 9, 2026Chuang Hao-YuanChief Financial OfficerSSaleAmerican depositary share−6.2K$181.5035−$1.13M93.8K−6.2%SEC10b5-1